Vantage Partners
JANUARY 19, 2024
Analysis from EY found that life sciences M&A spend was up 34% last year relative to 2022, despite a reduction in deal volume. It’s no great secret that M&A activity in bipoharma has been on the rise over the past 12 months.
Vantage Partners
JUNE 8, 2023
We’ve identified a number of deliverables that typically must be created in the first 100 days of a life sciences alliance launch.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Vantage Partners
JUNE 8, 2023
Over the course of our 25 years in the business, we've realized that when a life sciences company launches a complex alliance, the plan tends to gravitate towards two simultaneous paths: one focused on getting the work done and achieving specific milestones, and the other focused on setting things up (e.g.,
Vantage Partners
JUNE 10, 2021
This past year, alliance launches across the life sciences industry shifted from in-person to completely virtual.
Vantage Partners
OCTOBER 27, 2020
In case you missed them during the conference, Stu Kliman and Ben Siddall led a session on “Enhancing Partnerships between Life Sciences and Digital Organizations” and Mai-Tal Kennedy moderated a panel with Petra Sansom, Jay Vora, and Vin Sharma about “Making a Positive Impact on New Drug Modality Alliances.”.
Vantage Partners
DECEMBER 10, 2024
Vantage periodically executes a "State of Pharma Alliance Management" report, based on surveys, benchmarking studies, and informal conversations with Heads of Alliance Management across the industry.
Vantage Partners
JULY 3, 2024
Our team enjoyed presenting ( here's our presentation ) at Cambridge Healthtech Institute’s Strategic Alliance Management Congress in Philadelphia earlier this month. This conference is an annual highlight for us!
Expert insights. Personalized for you.
83 
Let's personalize your content